Dr Caroline Jenkinson
University of Exeter Medical School, RILD Building, RD&E Hospital Wonford, Barrack Road, Exeter, EX2 5DW, UK
Since December 2017, Caroline has been the Trial Coordinator for TriMaster, a randomised double-blind crossover study of a DPP4 inhibitor, SGLT2 inhibitor and thiazolidinedione as a second or third line therapy in patients with type 2 diabetes who have suboptimal glycaemic control on therapy with metformin-only or metformin and a sulphonylurea. Her main roles are to set up and monitor trial sites (n=20).
Caroline joined the University of Exeter in 2009 to evaluate the Every Child a Writer initiative in the Graduate School of Education. She soon joined Primary Care in 2010 and was based there until December 2017. During this time, she worked on three depression trials: MIR, CoBalT and TREAD. The MIR trial was is a double-blind, placebo controlled, randomised CTIMP investigating the addition of Mirtazapine to SSRIs or SNRIs for treatment resistant depression in primary care. CoBalT investigated the use of cognitive behavioural therapy for patients with treatment resistant depression and TREAD investigated the use of exercise in the management of patients with recently diagnosed depression. Previous projects include the third update of the Cochrane systematic review on psychological interventions and coronary heart disease, a systematic review and meta analysis investigating the impact of volunteering on the volunteers’ health, and the Check-Up Study which aimed to improve the uptake of the NHS cardiovascular health check in primary care.
- PhD Health Sciences
- BSc Food Science/Microbiology
Publications by category
Publications by year
Caroline_Jenkinson Details from cache as at 2018-06-19 04:16:37